The role of chromatin in HIV-1 transcriptional regulation

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 279-290

  Mirkovitch, Jovan ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMATIN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0031450342     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80048-4     Document Type: Article

References (65)

1. JONES , K. A., and B. M. PETERLIN. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annual review of Biochemistry 63: 717-743.
2. GARCIA, J. A., and R. B. GAYNOR. 1994. The human immunodeficiency virus type-1 long terminal repeat and its role in the gene expression. Progress in Nucleic Acid Research and Molecular Biology 49: 157-196.
3. KINGSTON, R. E., C. A. BUNKER, and A. N. IMBALZANO. 1996. Repression and activation by multiprotein complexes that alter chromatin structure. Genes & Development 10: 905-920.
4. FELSENFELD, G. 1996. Chromatin unfolds. 86: 13-19.
5. STEGER, D. J., and J. L. WORKMAN. 1996. Remodeling chromatin structures for transcription: what happens to the histones? BioEssays 18: 875-884.
6. PETERSON, C. L., and I. HERSKOWITZ. 1992. Characterization of the yeast SW11, SW12 and SW13 genes, which encode a global activator of transcription. Cell 68: 1135-1143.
7. CAIRNS, B. R., Y. LORCH, Y. LI, M. C. ZHANG, L. LACOMIS, H. ERDJUMENTBROMAGE, P. TEMPST, J. DU, B. LAURENT, and R. D. KORNBERG. 1996. RSC, an essential, abundant chromatin-remodeling complex. Cell 87: 1249-1260.
8. TSUKIYAMA, T., C. DANIEL, J. TAMKUN, and C. WU. 1995. ISWI, a member of the SW12/ SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor. Cell 83: 1021-1026.
9. ROTH, S. Y., and C. D. ALLIS. 1996. The subunit-exchange model of histone acetylation. Trends in Cell Biology 6: 371-375.
10. GARCIA-RAMIREZ, M., C. ROCCHINI, and J. AUSIO. 1995. Modulation of chromatin folding by histone acetylation. Journal of Biological Chemistry 270: 17923-17928.
11. LEE, D. Y., J. J. HAYES, D. PRUSS and A. P. WOLFFE. 1993. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72: 73-84.
12. KUO, M. H., J. E. BROWNELL, R. E. SOBEL, T. A. RANALLI, R. G. COOK, D. G. EDMONDSON, S. Y. ROTH, and C. D. ALLIS. 1996. Transcription-linked acetylation by GCN5p of histones H3 and H4 at specific lysines. Nature 383: 269-272.
13. MIZZEN, C. A., X. J. YANG, T. KOKUBO, J. E. BROWNELL, A. J. BANNISTER, T. OWENHUGHES, J. WORKMAN, L. WANG, S. L. BERGER, T. KOUZARIDES, Y. NAKATANI, and C. D. ALLIS. 1996. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 87: 1261-1270.
14. OGRYZKO, V. V., R. L. SCHILTZ, V. RUSSANOVA, B. H. HOWARD, and Y. NAKATANI. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
15. VERREAULT, A., P. D. KAUFMAN, R. KOBAYASHI, and B. STILLMAN. 1996. Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4. Cell 87: 95-104.
16. OWEN-HIGHES, T. A., and J. L. WORKMAN. 1994. Experimental analysis of chromatin function in transcription control. Critical Reviews in Eukaryotic Gene Expression 4: 403-441.
17. SHERIDAN, P. L., C. T. SHELINE, K. CANNON, M. L. VOZ, M. J. PAZIN, J. T. KADONAGA, and K. A. JONES. 1995. Activation of the HIV-I enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes & Development 9: 2090-2104.
18. PAZIN, M. J., P. L. SHERIDAN, K. CANNON, Z. CAO, J. G. KECK, J. T. KADONAGA, and K. A. JONES. 1996. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes & Development 10: 37-49.
19. JONES, K. A., J. T. KADONAGA, P. A. LUCIW, and R. TIJAN. 1986. Activation of the AIDS retrovirus promoter by the cellular transcription factor. Sp1. Science 232: 755-759.
20. KAMINE, J., R. SUBRAMANIAN, and G. CHINNADURAI. 1991. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 tat protein. Proceedings of the National Academy of Sciences (USA) 88: 8510-8514.
21. BERKHOUT, B., and K.-T. JEANG. 1992. Functional roles for the TATA promoter and enhancers in basal and tat-induced expression of the human immonodeficiency virus type 1 long terminal repeat. Journal of Viroloy 66: 139-149.
22. KIM, J. Y., S. F. GONZALEZ, S. L. ZEICHNER, and J. C. ALWINE. 1993. Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. Journal of Virology 67: 1658-1662.
23. NABEL, G., and D. BALTIMORE. 1987. An inducible transcription factor activates expression of human immonodeficiency virus in T cells. Nature 326: 711-713.
24. VERDIN, E., P. J. PARAS, and C. VAN LINT. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO Journal 12: 3249-32589.
25. VERDIN, E. 1991. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type I. Journal of Virology 65: 6790-6799.
26. VAN LINT, C., S. EMILIANI, M. OTT, and E. VERDIN. 1996. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO Journal 15: 1112-1120.
27. EMILIANI, S., C. VAN LINT, W. FISCHLE, P. J. PARAS, M. OTT, J. BRADY, and E. VERDIN. 1996. A point mutation in the HIV-1 Tat responsive element is asociated with postintegration latency. Proceedings of the National Academy of Sciences (USA) 93: 6377-6381.
28. FOLKS, T. M., K. A. CLOUSE, J. JUSTEMENT, A. RABSON, E. DUH, J. H. KEHRL, and A. S. FAUCI. 1989. Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proceedings of the National Academy of Sciences (USA) 86: 2365-2368.
29. FOLKS, T. M., J. JUSTEMENT, A. KINTER, S. SCHNITTMAN, J. ORENSTEIN, G. POLI, and A. S. FAUCI. 1988. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. The Journal of Immunology 140: 1117-1122.
30. POMERANTZ, R. J., D. TRONO, M. B. FEINBERG, and D. BALTIMORE. 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61: 1271-1276.
31. GROSS, D. S., and W. T. GARRARD. 1988. Nuclease hypersensitive sites in chromatin. Annual Review of Biochemistry 57: 159-197.
32. VAN LINT, C., J. GHYSDAEL, P. J. PARAS, A. BURNY, and E. VERDIN. 1994. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. Journal of Virology 68: 2632-2348.
33. EL KHARROUBI, A., and E. VERDIN. 1994. Protein-DNA interactions within DNaseI-hypersensitive sites located downstream of tl HIV-1 promoter. Journal of Biological Chemistry 269: 19916-19924.
34. EL KHARROUBI, A., and M. A. MARTIN. 1996. cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Molecular & Cellular Biology 16: 2958-2966.
35. GARCIA, J. A., F. K. WU, R. MITSUYASU, and R. B. GAYNOR. 1987. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO Journal 6: 3761-3770.
36. DEMARCHI, F., P. D'AGARO, A. FALASCHI, and M. GIACCA. 1992. Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting. Journal of Virology 66: 2514-2518.
37. DEMARCHI, F., P. D'AGARO, A. FALASCHI, and M. GIACCA. 1993. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. Journal of Virology 67: 7450-7460.
38. FRAGOSO, G., S. JOHN, M. S. ROBERTS, and G. L. HAGER. 1995. Nucleosome positioning on the MMTV LTR results from the frequency-biased occupancy of multiple frames. Genes & Development 9: 1933-1947.
39. THOMAS, G. H., and S. C. ELGIN. 1988. Protein/DNA architecture of the DNase I hypersentive region of the Drosophila hsp26 promoter. EMBO Journal 7: 2191-2201.
40. BROWN, S. A., A. N. IMBALZANO, and R. E. KINGSTON. 1996. Activator-dependent regulation of transcriptional pausing on nucleosomal templates. Genes & Development 10: 1470-1490.
41. KATO, H., H. SUMIMOTO, P. POGNONEC, C.-H. CHEN, C. A. ROSEN, and R. G. ROEDER. 1992. HIV-1 tat acts as a processivity factor in vitro in conjugation with cellular elongation factors. Genes & Develoment 6: 655-666.
42. MARCINIAK, R. A., and P. A. SHARP. 1991. HIV-1 tat protein promotes formation of more-processive elongation complexes. EMBO Journal 10: 4189-4196.
43. BLAIR, W. S., R. A. FRIDELL, and B. R. CULLEN. 1996. Synergistic enhancement of both initiation and elongation by acidic transcription activation domains. EMBO Journal 15: 1658-1665.
44. MIRKOVITCH, J. 1995. Mapping DNA-protein interactions in cells and nuclei: genomic sequencing by template purification. Methods in Enzymology. P. K. VOGT and I. M. VERMA. Academic Press 254: 579-595.
45. TRUSS, M., J. BARTSCH, A. SCHELBERT, R. J. HACHE, and M. BEATO. 1995. Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO Journal 14: 1737-1751.
46. DINGWALL, C., I. ERNBERG, M. J. GAIT, G. S. M., S. HEAPHY, J. KARN, A. D. LOWE, M. SINGH, M. A. SKINNER, and R. VALERIO. 1989. Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proceedings of the National Academy of Sciences (USA) 86: 6925-6929.
47. ROY, S., U. DELLING, C.-H. CHEN, C. A. ROSEN, and N. SONENBERG. 1990. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes & Development 4: 1365-1373.
48. WEEKS, K. M., C. AMPE, S. C. SCHULTZ, T. A. STEITZ, and D. M. CROTHERS. 1990. Fragments of the HIV-1 tat protein specifically bind tar RNA. Science 249: 1281-1285.
49. RAPPAPORT, J., S.-J. LEE, K. KHALILI, and F. WONG-STAAL. 1989. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. The New Biologist 1: 101-110.
50. BERKHOUT, B., A. GATIGNOL, A. B. RABSON, and K.-T. JEANG. 1990. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell 62: 757-767.
51. SOUTHGATE, C. D., and M. R. GREEN. 1991. The HIV-1 tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes & Development 5: 2496-2507.
52. LASPIA, M. F., A. P. RICE, and M. B. MATHEWS. 1989. HIV-1 tat protein increases transcriptional initiation and stabilizes elongation. Cell 59: 283-292.
53. LASPIA, M. F., A. P. RICE, and M. B. MATHEWS. 1990. Synergy between HIV-1 tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes & Development 4: 2397-2408.
54. KESSLER, M., and M. B. MATHEWS. 1991. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.. Proceedings of the National Academy of Sciences (USA) 88: 10018-10022.
55. KESSLER, M., and M. B. MATHEWS. 1992. Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts. Journal of Virology 66: 4488-4496.
56. ZHOU, Q., and P. A. SHARP. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO Journal 14: 321-328.
57. KASHANCHI, F., G. PIRAS, M. F. RADONOVICH, J. F. DUVALL, A. FATTAEY, C. M. CHIANG, R. G. ROEDER, and J. N. BRADY. 1994. Direct interaction of human TFIID with the HIV-1 transcactivator tat. Nature 367: 295-299.
58. KEEN, N. J., M. J. GAIT, and J. KARN. 1996. Human immunodeficiency virus type-1 tat is an integral component of the activated transcription-elongation complex. Proceedings of the National Academy of Sciences (USA) 93: 2505-2510.
59. MAVANKAL, G., S. OU, H. OLIVER, D. SIGMAN, and R. B. GAYNOR. 1996. Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II. Proceedings of the National Academy of Sciences (USA) 93: 2089-2094.
60. CHUN, R. F., and K. T. JEANG. 1996. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus i and HIV-I. Journal of Biological Chemistry 271: 27888-27894.
61. YANG, X. Z., C. H. HERRMANN, and A. P. RICE. 1996. The human immunodeficiency virus tat proteins specifically associated with tak in vivo and require the carboxy-terminal domain of RNA polymerase II for function. Journal of Virology 70: 4576-4584.
62. FEINBERG, M. B., D. BALTIMORE, and A. D. FRANKEL. 1991. The role of tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proceedings of the National Academy of Sciences (USA) 88: 4045-4049.
63. JEANG, K. T., B. BERKHOUT, and B. DROPULIC. 1993. Effects of integration and replication on transcription of the HIV-1 long terminal repeat. Journal of Biological Chemistry 268: 24940-24949.
64. HOWCROFT, T. K., K. STREBEL, M. A. MARTIN, and D. S. SINGER. 1993. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260: 1320-1322.
65. OU, M., S. EMILIANI, C. VAN LINT, G. HERBEIN, J. LOVETT, N. CHIRMULE, T. MCCLOSKEY, S. PAHWA, and E. VERDIN. 1997. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275: 1481-1485.